Dr.A.K. Mandal Urologist in Chandigarh

Dr.A.K. Mandal

Urologist, Chandigarh

MBBS, MS (General Surgery), M.Ch (Urology)

  • 1 Hospital

About

Dr. A.K. Mandal is a Urologist at Postgraduate Institute of Medical Education and Research in Chandigarh. He has completed his MBBS from the University of Calcutta in 1980, then he did his MS in General Surgery and MCH in Urology from PGIMER at Chandigarh.

Dr. Mandal is a Life Member of Urological Society of India (USI) and North Zone Chapter of the Urological Society of India (NZUSI). He is also a member of Société Internationale d'Urologie (SIU), Member of American Urological Association (AUA) and a Member of Urological Association of Asia (UAA).

Specialities

  • Urology

  • Reconstructive Surgery

  • Uro Oncology

Expertise

  • Voiding Dysfunction

Education

MBBS, 1980, University of Calcutta

MS (General Surgery), 1984, PGIMER, Chandigarh, India

M.Ch (Urology), 1988, PGIMER, Chandigarh, India

Practice Information

Postgraduate Institute of Medical Education and Research, Chandigarh

Postgraduate Institute of Medical Education and Research, Chandigarh

Sector-12, Chandigarh, Chandigarh - 160012

Achievements & Contributions

  • Iatrogenic ureteral injury in General Surgical Practice: Preventioand Management. In Clinical Surgery – A comprehensive update.2001 Edition by Dr. J.D. Wig. pp: 189-193
  • Management of Neurogenic Bladder – The current status (eds.BS Sharma and UK Mishra) In Progress in Clinical Neurosciences 2004;19:226-260)
  • Common Urological Problems (eds.R Kumar and M Kumar) in Guide to Prevention of Life Style Diseases.2004:179-198
  • Choudhary MK, Agarwal MM, Mandal AK, MavuduruRM and Singh SK. A study of normative flow-volume relations in healthy indianwomen in squatting  voiding position:reappraisal of applicability of Liverpool nomogram in this  population.Eur Urol Suppl. 2011, 10(2): 288
  • Kumar S, Ganesamoni R, Mandal AK, Prasad S,Singh SK. Dimethyl sulfoxide with lignocaine versus euthectic mixture of localanesthetics: prospective randomized study to compare the efficacy of cutaneousanesthesia in shock wave lithotripsy.Urol Res 2011; 39(3):181-3
  • Kumar S,Sandeep, Ganesamoni R, Mandal AK. Efficacy and outcome of percutaneous    nephrolithotomy in patients with calculus    nephropathy.   Uro.Res.2011;39(2):111-5
  • Sarkar D, Singh SK, Mandal AK et al. Plasma chromogranin A: Clinical Implications in patients with castrate resistant prostate cancer receiving docetaxel chemotherapy. Cancer Biomarkers 2011; 8: 81-87
  • Ganesamoni R, Bhattacharyya S, Kumar S, Chauhan A,Mete UK, Agarwal MM, Mavuduru R, Kaushik G, Mandal AK, Singh SK. Statusof oxidative stress in patients with renal cell carcinoma. J Urol2012;187(4):1172
  • Kumar S, Bag S, Ganesamoni R, Mandal AK, RanejaN, Singh SK.  Risk factors for urosepsisfollowing percutaneous nephrolithotomy: role of 1 week of nitrofurantoin inreducing the risk of urosepsis. Urol Res 2012;40(1):79-86
  • Agarwal MM, Mavuduru RM, Singh SK, Mandal AK .Preliminary short-term outcomes of a modified double-T ileal continent cutaneousurinary diversion using Yang-Monti tube implantation through serosa-linedextramural tunnel: The PGIMER pouch. Urology 2012, 79(4): 943-9
  • Bala I, BhartiN, Chaubey VK and Mandal AK. Efficacy of Gabapentin for prevention ofpostoperative catheter-related bladder discomfort in patients undergoingtransurethral resection of bladder tumour Urology 2012, 79(4): 853-857
  • Sharma U, Singh SK, Pal D, Khajuria R, Mandal AKand Prasad R. Implication of BBM lipid composition and fluidity in mitigatedalkaline phosphatise activity in renal cell carcinoma.Mol.Cell Biochem 2012,369: 287 – 293
  • Agarwal MM, Ramaya SM, Mandal AK and Singh SK,Voiding dysfunction after repair of giant trigonal vesicovaginal orurethrovaginal fistulae – A need for long term follow up. Ind. J. Urol.2012;28:405-5
  • Sharma Ujjawal,Singh SK,Mandal AK et al.Implication of BBM lipid composition and fluidity in mitigated alkaline phosphatase activity in renal cell carcinoma. Mol cell biochem 2012;369:287-293
  • Priyadarshini A, Chakraborti A, Mandal AK and Singh SK.  Asp299Gly and Thr399Ile polymorphism of TLR-4gene in patients with prostate cancer from North India Indian. J. Urol. 2013,29:37 – 41
  • Agarwal MM,Patil S, Roya K, Bandeawar M, Choudhary S, Mavuduru R, Sharma SK, Mandal AKand Singh SK. Rationalisation of interpretation of uroflowmetry for aNon-caucasian (Indian) population, conceptual development and validation ofvolume-normalised Flow rate index.Neurourology and Urodynamics. 2013 Feb. 22.(Epub ahead of print)
  • Manohar K,Bhattacharya A, Vyas S, Dey P,Mandal AK, Abrar ML and Mittal BR.      Metastatic lung nodule diagnosed on 18F-FDG PET/CT guided fine needle  aspirationin a patient with renal cell carcinoma Clinical Nuclear Medicine. Vol 38,  Number 1, 2013
  • Barapatre YR,Agarwal MM, Mavuduru RM, Sharma SK, Kumar S, Singh SK and     Mandal AK. Short-term functionaland urodynamic outcome of W-Ileal orthotopic neobladderwith serosa-linedtunnelled uretero-ileal anastomosis LUTS 2013 (accepted)
  • Kuruva M, Bhattacharya A,Mandal AK. Metastatic Lung Nodule Diagnosed on 18F-FDG PET/CT-Guided Fine Needle Aspiration in a Patient with Renal Cell Carcinoma. clinical nuclear medicine.2013; 38:e38-e39
  • Life Member, Urological Society of India (USI)
  • Life Member, North Zone Chapter of the Urological Society of India (NZUSI)
  • Life Member, Urolithiasis Society of India
  • Member, Societe InternationaledÂ’ Urologie (SIU)
  • Member, Americal Urological association (AUA)
  • Member, Urological Association of Asia (UAA)
-->